Novartis Oncology Controller Salaries in Ithaca, NY | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
13
TOTAL
RATINGS
160

Novartis Oncology Controller Salaries in Ithaca, NY

The average Novartis Oncology Controller in Ithaca, NY earns an estimated $116,461 annually. Novartis Oncology's Controller compensation is $6,818 less than the US average for a Controller.

In Ithaca, NY, The Finance Department at Novartis Oncology earns $14,735 more on average than the Customer Support Department.

Last updated 2 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$116,461
Average Compensation
$116,461
avg. base

Controller Salaries at Novartis Oncology

In Ithaca, NY, Controllers earn $26,180 more than Senior Accountants, and $2,441 less than Accounting Managers.

Accounting Manager
$119k*
Senior Accountant
$90k*
Financial Analyst
$90k*
Business Analyst
$88k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Ithaca, NY, The Finance Department averages $14,735 more than the Customer Support Department, and $8,543 less than the Operations Department

Operations
$89,724 Avg. total comp.
+$9k
Finance
$81,181 Avg. total comp.
Customer Support
$66,446 Avg. total comp.
-$15k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Novartis Oncology reported making $138,290, while the average male Controller at similar sized companies reported making $133,282.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Novartis Oncology reported making $132,409, while the average Caucasian Controller at similar sized companies reported making $129,306.

How Controllers at Novartis Oncology Rate Their Compensation

The majority of Controllers at Novartis Oncology believe they're not compensated fairly. 100% of Controllers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company